Henry Schein Enters Fast-Growing Dental Market in Turkey

Full-Service Distributor Holds a Leading Market Position

MELVILLE, New York, October 27, 2010 - Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care
products and services to office-based practitioners, today announced it has
acquired a 50% non-consolidating interest in Guney Dis Deposu (Guney), a
full-service dental distribution business headquartered in Istanbul, Turkey.
The remaining 50% will be held by Ferizan Peker, whose family founded Guney
in 1950. For the past 40 years Mr. Peker has managed Guney, a leader in the
EUR 90 million (USD$126 million) Turkish dental market. Henry Schein expects
the transaction to be neutral to 2010 earnings per share, and slightly
accretive to 2011 earnings per share. Financial terms were not disclosed.

"The Turkish dental market is growing rapidly at approximately 10% to 12%
per year, and our investment in Guney brings to Henry Schein a
well-respected, market-leading business with a 60-year history," said Stanley
M. Bergman, Chairman and Chief Executive Officer of Henry Schein. "This
strong history has been supported by a successful distribution model that we
expect to maintain in order to continue to drive future sales growth."

Mr. Bergman continued, "We are fortunate that the Guney name is
well-respected in Turkey, and that the company has exclusive distribution
rights with many manufacturers. We see considerable growth opportunity in
Turkey, including focusing on under-penetrated brands, and introducing
certain new brands and Henry Schein private-label products."

With approximately 70 team members, Guney's operations are supported from
a centralized warehouse in Istanbul. Guney had sales of EUR 17 million
(USD$24 million) for the past 12 months, of which approximately 60% were from
dental equipment, 35% from dental consumables and 5% from technical service.

There are approximately 23,000 dentists in Turkey; of which approximately
63% were in private practice in 2008. There is a growing trend in aesthetic
dentistry and the government is accelerating its investment in dental and
oral care.

With Henry Schein's entry into the Turkish market, the Company now has
operations or affiliates in 23 countries outside of the United States,
including: Australia, Austria, Belgium, Canada, China, the Czech Republic,
France, Germany, Hong Kong SAR, Iceland, Ireland, Israel, Italy, Luxembourg,
the Netherlands, New Zealand, Portugal, Saudi Arabia, Spain, Switzerland, the
United Arab Emirates, and the United Kingdom

About Henry Schein

Henry Schein, a Fortune 500(R) company and a member of the NASDAQ 100(R)
Index, is recognized for its excellent customer service and highly
competitive prices. The Company's five businesses - North American Dental,
North American Medical, North American Animal Health, International and
Technology - serve nearly 700,000 customers worldwide, including dental
practitioners and laboratories, physician practices and animal health
clinics, as well as government and other institutions. The Company operates
through a centralized and automated distribution network, which provides
customers in more than 200 countries with a comprehensive selection of more
than 90,000 national and Henry Schein private-brand products in stock, as
well as more than 100,000 additional products available as special-order
items. Henry Schein also provides exclusive, innovative technology offerings
for dental, medical and veterinary professionals, including value-added
practice management software and electronic health record solutions.

Headquartered in Melville, N.Y., Henry Schein employs more than 13,500
people and has operations or affiliates in 24 countries. The Company's net
sales reached a record USD$6.5 billion in 2009. For more information, visit
the Henry Schein Web site at www.henryschein.com.

In accordance with the "Safe Harbor" provisions of the Private Securities
Litigation Reform Act of 1995, we provide the following cautionary remarks
regarding important factors that, among others, could cause future results to
differ materially from the forward-looking statements, expectations and
assumptions expressed or implied herein. All forward-looking statements made
by us are subject to risks and uncertainties and are not guarantees of future
performance. These forward-looking statements involve known and unknown
risks, uncertainties and other factors that may cause our actual results,
performance and achievements or industry results to be materially different
from any future results, performance or achievements expressed or implied by
such forward-looking statements. These statements are identified by the use
of such terms as "may," "could," "expect," "intend," "believe," "plan,"
"estimate," "forecast," "project," "anticipate" or other comparable terms. A
full discussion of our operations and financial condition, including factors
that may affect our business and future prospects, is contained in documents
we have filed with the SEC and will be contained in all subsequent periodic
filings we make with the SEC. These documents identify in detail important
risk factors that could cause our actual performance to differ materially
from current expectations.

Risk factors and uncertainties that could cause actual results to differ
materially from current and historical results include, but are not limited
to: decreased customer demand and changes in vendor credit terms; disruptions
in financial markets; general economic conditions; effects of a highly
competitive market; changes in the healthcare industry; changes in regulatory
requirements; risks from expansion of customer purchasing power and
multi-tiered costing structures; risks associated with our international
operations; fluctuations in quarterly earnings; our dependence on third
parties for the manufacture and supply of our products; transitional
challenges associated with acquisitions, including the failure to achieve
anticipated synergies; financial risks associated with acquisitions;
regulatory and litigation risks; the dependence on our continued product
development, technical support and successful marketing in the technology
segment; risks from disruption to our information systems; our dependence
upon sales personnel, manufacturers and customers; our dependence on our
senior management; possible increases in the cost of shipping our products or
other service issues with our third-party shippers; risks from rapid
technological change; possible volatility of the market price of our common
stock; certain provisions in our governing documents that may discourage
third-party acquisitions of us; and changes in tax legislation. The order in
which these factors appear should not be construed to indicate their relative
importance or priority.

We caution that these factors may not be exhaustive and that many of
these factors are beyond our ability to control or predict. Accordingly, any
forward-looking statements contained herein should not be relied upon as a
prediction of actual results. We undertake no duty and have no obligation to
update forward-looking statements.

Investors: Steven Paladino, Executive Vice President and Chief Financial Officer, +1-631-843-5500, steven.paladino at henryschein.com, or Media: Susan Vassallo, Vice President, Corporate Communications, +1-631-843-5562, susan.vassallo at henryschein.com